INS and anaphylaxis: In patients not receiving Neutral Protamine Hagedorn (NPH) insulin and protamine-zinc insulin (PZI), the incidence of hypotensive adverse reactions is reported to be 0.06%, whereas anaphylaxis-like reactions (severe hypotensive reactions) in patients receiving NPH insulin are shown to be 0.6% [1, 10, 11].